No Data
Takeda-backed Ascentage Pharma Files for $100M IPO
Sangamo Says Collaboration, License Agreement With Pfizer On Giroctocogene Fitelparvovec Will Terminate Effective April 21, 2025; Plans To Explore All Options To Commercialize The Asset, Including Seeking Potential New Partner
Trim the Mag 7 and Invest in Lower Valuation Dividend Growth Stocks – Miramar Capital
Behind the Scenes of Texas Instruments's Latest Options Trends
10 Industrials Stocks With Whale Alerts In Today's Session
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
